Delivery Order SPE2DB20D1100-SPE2DB24FZ97X
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $2,035.41 firm fixed-price delivery order is for the supply of Telmisartan 20 mg tablets, a cardiovascular medication. The contract has an ultimate completion date of April 21, 2022. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $90,191.19 for the supply of Telmisartan-HCTZ 40-12.5 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has an ultimate completion date of December 1, 2023 and is a firm fixed-price type. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,915.95 firm-fixed-price delivery order is for the supply of Telmisartan 80 mg tablets. It is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for AmerisourceBergen...
- This federal contract award is for the delivery of Telmisartan 80 mg tablets to the Defense Logistics Agency (DLA). The $22,388.68 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of December 7, 2023 and does not have a set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
- This federal contract award, valued at $1,891.55, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Telmisartan-HCTZ 40-12.5 mg tablets, a cardiovascular medication, to support military treatment facilities and other federal medical institutions. The contract has an ultimate completion date of January 29, 2024 and is a Firm Fixed Price Delivery Order, with no set-aside designation....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,682.75 Firm Fixed Price Delivery Order contract is for the supply of Telmisartan-HCTZ 80-25 mg tablets. The contract has an ultimate completion date of February 13, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,804.82, is a delivery order contract for the supply of telmisartan-amlodipine 40-5 mg medication. The contract has an ultimate completion date of December 5, 2023 and is a firm fixed-price arrangement. Amerisourcebergen Drug Corp is a subsidiary of the parent company, Cencora, Inc., which has a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,986.54 firm fixed-price delivery order is for the supply of 4,567,299,271 units of the drug Telmisartan 40 mg tablets. The contract has an ultimate completion date of February 19, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The $6,102.20 firm fixed-price delivery order is for the supply of Telmisartan-HCTZ 40-12.5 mg tablets in 30-count unit doses. This award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award, valued at $7,183.74, is for the delivery of Telmisartan 20 mg tablets. The contract is a firm fixed-price Delivery Order with an ultimate completion date of April 26, 2024. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB24FZ97XDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $3,237.60 firm fixed-price delivery order is for the supply of Telmisartan 80 mg tablets. The award has an ultimate completion date of January 31, 2024. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical commodities. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.2k | 1/30/24 |